Huaren Pharmaceutical Co., Ltd.

¥2.66As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300110Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (11.18%)
Div yield —
ROE (41.27%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.39
PE TTM —
TSR TTM (21.76%)
Mkt cap ¥3.145B
ROIC 5.49%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥2.59
(2.51%)
(48.40%)
Buy 12|7|6|11|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.08
0.08
0.08
0.08
30.14%
31.32%
18.54%
20.80%
Revenue¥M
136.2
142.4
139.4
140.3
(1.64%)
2.17%
(0.70%)
0.48%
Peers (US$471.4M)
Cap (US$)
PE
476.6M
—
473.0M
17.48x
Capital
TTM
5Y
10Y
Leveragex
0.568
1.320
1.143
EBIT/Intx
11.14
1.126
1.000
Own earn%
68.29
(46.53)
(43.33)
Sh yield%
25.96
8.95
14.13
Owners
Insiders/Inst%
2.14
31.75
Short interest%
4.70
SBC / revenue%
4.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
9–17
$1 testx
0.0
Incr. ROIC%
7